4 papers in the library · 160 citations · publishing 2006-2020
Journal of Clinical Psychopharmacology October 2, 2020 Maximilian Gahr, Julia Ziller, Ferdinand Keller et al. 1 citation
Gahr, Maximilian MD; Ziller, Julia MD; Keller, Ferdinand PhD; Schönfeldt-Lecuona, Carlos MDAuthor Information
Journal of Addiction Medicine 2013 Christian Blacha, Markus M. Schmid, Maximilian Gahr et al. 17 citations
BACKGROUND: Genital self-mutilation is a well-known phenomenon in patients with schizophrenia and has occasionally been described in patients with personality disorders or transsexuality. However, literature just provides few cases of genital self-mutilation related to the use of psychotropic substances. CASE DESCRIPTION: A previously mentally healthy man (age, 32 years) performed manual...
Journal of Psychiatry and Neuroscience October 20, 2011 Nadine Donata Wolf, Fabio Sambataro, Nenad Vasić et al. 138 citations
BACKGROUND: Functional neuroimaging studies on schizophrenia have suggested abnormal task-related functional connectivity in patients with schizophrenia who have auditory verbal hallucinations (AVHs). However, little is known about intrinsic functional connectivity in these patients. METHODS: Between January 2009 and February 2010, we studied patients with schizophrenia who had persistent and...
Journal of Psychopharmacology November 1, 2006 Roland W. Freudenmann, Carlos Schönfeldt-lecuona, Manfred Spitzer et al. 4 citations
Depression in former ecstasy users may not respond to selective serotonin reuptake inhibitors (SSRIs) possibly due to damaged serotonergic synapses following long-term heavy ecstasy use. We report findings in a patient suffering from MDMA-induced depression which was refractory to several antidepressive medications including selective noradrenergic reuptake inhibitor (SNRI) and SSRI. An add-on...